BRT provides specialized preclinical research services across in vivo, in vitro, ex vivo, and bioanalytical approaches to evaluate immune safety, function, and therapeutic efficacy. Our customized research programs are designed around each client’s scientific objectives.
BRT provides integrated in vivo, in vitro, ex vivo, and bioanalytical capabilities to support customized preclinical research programs.
Rodent-based models to evaluate immune function, host resistance, and therapeutic efficacy.
Human cell-based and other in vitro assays to evaluate immune function and mechanistic responses.
Connecting mechanistic insight with functional outcomes through integrated in vitro, in vivo, ex vivo, and bioanalytical capabilities.
BRT works with clients to develop customized study designs based on specific research objectives, test articles, and endpoints. Our in vivo, in vitro, ex vivo, and bioanalytical capabilities can be integrated to support individual program needs.
